Literature DB >> 2007144

Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide.

I Clark-Lewis1, B Moser, A Walz, M Baggiolini, G J Scott, R Aebersold.   

Abstract

Two recently identified pro-inflammatory proteins, namely, neutrophil activating peptide 1 (NAP-1) [also termed interleukin-8 (IL-8)] and NAP-2, were chemically synthesized, purified, and characterized. The fully protected NAP-1/IL-8 (72 residues) and NAP-2 (70 residues) peptide chains were assembled by automated solid-phase methods with average stepwise yields of 99.5 and 99.3%, resulting in overall chain assembly yields of 70 and 62%, respectively. Deprotection resulted in crude products, which were allowed to fold by air oxidation, and were purified by two cycles of reverse-phase high-pressure liquid chromatography, yielding 27 mg of NAP-1/IL-8 and 22 mg of NAP-2. Purity was established by reverse-phase high-pressure liquid chromatography and isoelectric focusing, and the primary structures of the purified products were verified by using mass spectrometry and Edman sequencing methods. Synthetic and recombinant NAP-1/IL-8 were equally active on human neutrophil granulocytes as determined by measuring the induction of cytosolic free calcium, elastase release, and chemotaxis. Synthetic NAP-2 was equivalent to purified natural NAP-2 in the elastase release and calcium mobilization assays, but it was consistently less potent (3-5-fold) as a stimulus of chemotaxis, perhaps indicative of additional chemotactic components in the natural preparation. The results indicate that by chemical synthesis these cytokines can be obtained in purity and quantities suitable for further structural analysis, as well as functional studies both in vivo and in vitro.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2007144     DOI: 10.1021/bi00226a021

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  37 in total

1.  High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.

Authors:  M Uguccioni; C R Mackay; B Ochensberger; P Loetscher; S Rhis; G J LaRosa; P Rao; P D Ponath; M Baggiolini; C A Dahinden
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2.

Authors:  S A Jones; M Wolf; S Qin; C R Mackay; M Baggiolini
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

3.  A natural CCL5/RANTES variant antagonist for CCR1 and CCR3.

Authors:  Corinne Capoulade-Métay; Ahidjo Ayouba; Anfumbom Kfutwah; Kavita Lole; Stéphane Pêtres; Yasmine Dudoit; Philippe Deterre; Elisabeth Menu; Françoise Barré-Sinoussi; Patrice Debré; Ioannis Theodorou
Journal:  Immunogenetics       Date:  2006-06-22       Impact factor: 2.846

4.  Systemic neutralization of interleukin-8 markedly reduces neutrophilic pleocytosis during experimental lipopolysaccharide-induced meningitis in rabbits.

Authors:  R A Dumont; B D Car; N N Voitenok; U Junker; B Moser; O Zak; T O'Reilly
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

5.  Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture.

Authors:  M C Gershengorn; E Geras-Raaka; A Varma; I Clark-Lewis
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

6.  The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines.

Authors:  A S Lalani; K Graham; K Mossman; K Rajarathnam; I Clark-Lewis; D Kelvin; G McFadden
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

7.  Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis.

Authors:  P S Topham; V Csizmadia; D Soler; D Hines; C J Gerard; D J Salant; W W Hancock
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

8.  G-protein activation by interleukin 8 and related cytokines in human neutrophil plasma membranes.

Authors:  R W Kupper; B Dewald; K H Jakobs; M Baggiolini; P Gierschik
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

9.  Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells.

Authors:  B Moser; L Barella; S Mattei; C Schumacher; F Boulay; M P Colombo; M Baggiolini
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

10.  Mutational and functional analysis of dominant SPT2 (SIN1) suppressor alleles in Saccharomyces cerevisiae.

Authors:  L Lefebvre; M Smith
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.